Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Thomas Mulier
Stay informed with Thomas Mulier’s coverage and analysis for Fortune.
Health
WHO official downplays COVID variant discovered in France
By
Marthe Fourcade
,
Thomas Mulier
, and others
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By
Thomas Mulier
,
Riley Griffin
, and others
International
Europe overtakes U.S. as COVID-19 hotspot as infections surge
By
Thomas Mulier
and
Bloomberg
Retail
Lysol sales surge as the condom business goes limp under lockdown, consumer goods giant reports
By
Thomas Buckley
,
Thomas Mulier
, and others
Retail
Investors sink shares in online retailer Boohoo on reports of labor abuses in its supply chain
By
Thomas Mulier
,
Deirdre Hipwell
, and others
International
The 1-meter rule: virologists pan high fives, ‘bro hugs,’ and kissing as the coronavirus spreads
By
Thomas Mulier
,
Marthe Fourcade
, and others
Papa John’s Charts a Path Forward—Without Papa John
By
Thomas Mulier
,
Anne Riley Moffat
, and others
Drugmaker Lilly to Launch a Half-Price, Generic Version of Its Top-Selling Insulin
By
Bloomberg
and
Thomas Mulier